Lonza small-scale plant in China up and running
Lonza's small-scale plant (SSP) in Nansha Guangzhou, China, has begun operations. After having accomplished a five-day process on schedule, the product was tested and met all the standards and requirements.
Lonza's small-scale plant (SSP) in Nansha Guangzhou, China, has begun operations. After having accomplished a five-day process on schedule, the product was tested and met all the standards and requirements.
The Nansha facility, which operates under cGMP conditions, is designed to accommodate a greater number of reactors and includes a dedicated and technologically advanced Quality Control lab capable of fulfilling the ever increasing requirements of the global regulatory authorities.
In the completed first build-out phase, further smaller reactors including distillation and filtration units are installed, capable of handing a broad range of technologies. The configuration ensures fast change over, optimised efficiencies and extremely rapid technical transfer to commercial assets. Additional capacity can be added without affecting the running operations.
The plant is designed for production of quantities from 10kg up to several hundreds of kilograms, and closes the gap between Nansha's kilo lab and commercial production assets to allow complete life-cycle support for pharmaceutical products out of China. The commercial scale API (active pharmaceutical ingredients) facility in Nansha is currently under construction and will go online in the second half of 2008.